Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 11Uterine Cervical Neoplasms 7Endometrial Neoplasms 6Breast Neoplasms 6Vulvar Neoplasms 2Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Peritoneal Neoplasms 2Genital Neoplasms, Female 2Colorectal Neoplasms 2Vomiting 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Stomach Neoplasms 1Sexually Transmitted Diseases 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neoplastic Syndromes, Hereditary 1Neoplasms 1Nausea 1Mental Disorders 1Malnutrition 1Lymphoma 1Hypergammaglobulinemia 1Gestational Trophoblastic Tumours 1Fallopian Tube Neoplasms 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Exanthema 1Disease 1Dermatitis, Seborrheic 1

Interventions

Surveys and Questionnaires 1Standard of Care 1Interviews as Topic 1High-Throughput Nucleotide Sequencing 1Genetic Testing 1Genetic Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Syndromes, Hereditary × Interviews as Topic × Gynecologic × Clear all
NCT04763915 2025-09-19

IMPACT

Vanderbilt-Ingram Cancer Center

Phase NA Active not recruiting
720 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡